|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
1
|
|
pubmed:dateCreated |
1999-4-1
|
|
pubmed:abstractText |
Cisplatin (CDDP) and radiotherapy are frequently used concomitantly in the treatment of various malignant conditions. Because of its toxicity, cisplatin tends to be replaced by carboplatin (CBDCA) in several indications. Available data regarding the combined effects of cisplatin and carboplatin with ionising radiation are contradictory.
|
|
pubmed:language |
fre
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:issn |
1278-3218
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
3
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
30-8
|
|
pubmed:dateRevised |
2006-11-15
|
|
pubmed:meshHeading |
pubmed-meshheading:10083861-Carboplatin,
pubmed-meshheading:10083861-Cell Survival,
pubmed-meshheading:10083861-Cisplatin,
pubmed-meshheading:10083861-Drug Resistance, Neoplasm,
pubmed-meshheading:10083861-Female,
pubmed-meshheading:10083861-Humans,
pubmed-meshheading:10083861-Radiation, Ionizing,
pubmed-meshheading:10083861-Radiation Tolerance,
pubmed-meshheading:10083861-Radiation-Sensitizing Agents,
pubmed-meshheading:10083861-Tumor Cells, Cultured
|
|
pubmed:articleTitle |
[Interactions of carboplatin, cisplatin, and ionizing radiation on a human cell line of ovarian cancer].
|
|
pubmed:affiliation |
Service de radiothérapie oncologique, clinique universitaire Saint-Luc, Bruxelles, Belgique.
|
|
pubmed:publicationType |
Journal Article,
English Abstract,
Research Support, Non-U.S. Gov't
|
